Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
DICE (dexamethasone, ifosfamide, cisplatin, etoposide) infusional chemotherapy for refractory or relapsed non-Hodgkin's lymphoma (NHL).
Eur J Haematol Suppl. 2001 Jul;64:41-5.
Eur J Haematol Suppl. 2001.
PMID: 11486401
Clinical Trial.
Prednisone, etoposide, procarbazine, and cyclophosphamide (PEP-C) oral combination chemotherapy regimen for recurring/refractory lymphoma: low-dose metronomic, multidrug therapy.
Coleman M, Martin P, Ruan J, Furman R, Niesvizky R, Elstrom R, George P, Kaufman TP, Leonard JP.
Coleman M, et al. Among authors: kaufman tp.
Cancer. 2008 May 15;112(10):2228-32. doi: 10.1002/cncr.23422.
Cancer. 2008.
PMID: 18338745
Free article.
Clinical Trial.
Item in Clipboard
Augmented therapy of extensive Hodgkin's disease: radiation to known disease or prolongation of induction chemotherapy did not improve survival--results of a Cancer and Leukemia Group B study.
Coleman M, Rafla S, Propert KJ, Glicksman A, Peterson B, Nissen N, Brunner K, Holland JF, Anderson JR, Gottlieb A, Kaufman T.
Coleman M, et al.
Int J Radiat Oncol Biol Phys. 1998 Jun 1;41(3):639-45. doi: 10.1016/s0360-3016(98)00071-6.
Int J Radiat Oncol Biol Phys. 1998.
PMID: 9635714
Clinical Trial.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.